Publication

Canakinumab for Treatment of Adult-Onset Still's Disease to Achieve Reduction of Arthritic Manifestation (CONSIDER): phase II, randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial

Journal Paper/Review - May 13, 2020

Kedor Claudia, Specker Christof, Seipelt Eva, Schulze-Koops Hendrik, Rubbert-Roth Andrea, Kekow Joern, Henes Joerg Christoph, Blank Norbert, Behrens Frank, Weiß Anja, Zernicke Jan, Listing Joachim, Feist Eugen